Antithrombotic therapy management in atrial fibrillation patients with acute coronary syndrome or undergoing percutaneous coronary intervention is reviewed.
Tasa de eventos absoluta: 0% vs 0%
International audience
Lip et al. (Tue,) reported a other. Antithrombotic therapy management in atrial fibrillation patients with acute coronary syndrome or undergoing percutaneous coronary intervention is reviewed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: